Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
C US​

Citigroup Inc.(C US)

$120.62-1.891.54%Ext:$120.52-0.100.09%(Market Closed · 23:59:20 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner
EDINET Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

Financials(128)

Expand
  • 10-QQ2ended 30 Jun 20266 Aug
  • 10-QQ1ended 31 Mar 20267 May
  • 10-KFY 2025ended 31 Dec 202520 Feb
  • 10-QQ3ended 30 Sept 20256 Nov 2025
  • 10-QQ2ended 30 Jun 20256 Aug 2025
  • 10-QQ1ended 31 Mar 20258 May 2025
  • 10-KFY 2024ended 31 Dec 202421 Feb 2025
  • 10-QQ3ended 30 Sept 20247 Nov 2024
  • 10-QQ2ended 30 Jun 20242 Aug 2024
  • 10-QQ1ended 31 Mar 20243 May 2024
  • 10-KFY 2023ended 31 Dec 202323 Feb 2024
  • 10-QQ3ended 30 Sept 20233 Nov 2023
  • 10-QQ2ended 30 Jun 20234 Aug 2023
  • 10-QQ1ended 31 Mar 20235 May 2023
  • 10-KFY 2022ended 31 Dec 202227 Feb 2023

Events(996)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers22 Oct
  • 8-K​​​​​Citigroup($ in millions, except per share amounts and as otherwise noted)​ ​ ​3Q’26​ ​ ​2Q’26​ ​ ​3Q’25​ ​ ​QoQ%​ ​ ​YoY%Total revenues, net of interest expense​23,845​24,766​22,090​(4)%​8%​​​​​​​​​​​Total operating expenses​13,952​14,215​14,290​(2)%​(2)%​​​​​​​​​​​Net credit losses​2,217​2,404​2,214​(8)%​-Net ACL build / (release)(a)​333​102​145​226%​130%Other provisions(b)​36​16​91​125%​(60)%Total provision for credit losses​2,586​2,522​2,450​3%​6%​​​​​​​​​​​Income (loss) from continuing operations before taxes​7,307​8,029​5,350​(9)%​37%Provision for income taxes​1,887​2,005​1,559​(6)%​21%Income (loss) from continuing operations​5,420​6,024​3,791​(10)%​43%Income (loss) from discontinued operations, net of taxes​-​-​(1)​-​100%Net income attributable to non-controlling interest​175​193​38​(9)%​361%Citigroup’s net income (loss)​$5,245​$5,831​$3,752​(10)%​40%​​​​​​​​​​​​​​​​​​​​​​EOP loans ($B)​820​794​734​3%​12%Average loans ($B)​809​785​725​3%​12%EOP assets ($B)​2,941​2,895​2,642​2%​11%EOP deposits ($B)​1,505​1,493​1,384​1%​9%Average deposits ($B)​1,528​1,504​1,382​2%​11%​​​​​​​​​​​​​​​​​​​​Book value per share​$115.61​$114.74​$108.41​1%​7%Tangible book value per share(c)​$101.59​$100.89​$95.72​1%​6%Common Equity Tier 1 (CET1) Capital ratio(d)​12.8%​12.8%​13.3%​​​​Supplementary Leverage ratio (SLR)(d)​5.0%​5.2%​5.5%​​​​Return on average common equity (ROE)(e)​10.1%​11.4%​7.1%​(130) bps​300 bpsReturn on average tangible common equity (RoTCE)(f)​11.5%​13.0%​8.0%​(150) bps​350 bpsEfficiency Ratio (total operating expenses/total revenues, net)​58.5%​57.4%​64.7%​110 bps​(620) bps13 Oct
  • 8-KFinancial Statements and Exhibits24 Sep
  • 8-K​​​​​Citigroup($ in millions, except per share amounts and as otherwise noted)​ ​ ​2Q’26​ ​ ​1Q’26​ ​ ​2Q’25​ ​ ​QoQ%​ ​ ​YoY%Total revenues, net of interest expense​24,766​24,633​21,668​1%​14%​​​​​​​​​​​Total operating expenses​14,215​14,311​13,577​(1)%​5%​​​​​​​​​​​Net credit losses​2,404​2,208​2,234​9%​8%Net ACL build / (release)(a)​102​581​224​(82)%​(54)%Other provisions(b)​16​16​414​-​(96)%Total provision for credit losses​2,522​2,805​2,872​(10)%​(12)%​​​​​​​​​​​Income (loss) from continuing operations before taxes​8,029​7,517​5,219​7%​54%Provision for income taxes​2,005​1,578​1,186​27%​69%Income (loss) from continuing operations​6,024​5,939​4,033​1%​49%Income (loss) from discontinued operations, net of taxes​-​(1)​-​100%​-Net income attributable to non-controlling interest​193​153​14​26%​NMCitigroup’s net income (loss)​$5,831​$5,785​$4,019​1%​45%​​​​​​​​​​​​​​​​​​​​EOP loans ($B)​794​762​725​4%​9%Average loans ($B)​785​755​712​4%​10%EOP assets ($B)​2,895​2,778​2,623​4%​10%EOP deposits ($B)​1,493​1,446​1,358​3%​10%Average deposits ($B)​1,504​1,446​1,343​4%​12%​​​​​​​​​​​​​​​​​​​​Book value per share​$114.74​$112.22​$106.94​2%​7%Tangible book value per share(c)​$100.89​$99.01​$94.16​2%​7%Common Equity Tier 1 (CET1) Capital ratio(d)​12.8%​12.7%​13.5%​​​​Supplementary Leverage ratio (SLR)(d)​5.2%​5.3%​5.5%​​​​Return on average common equity (ROE)(e)​11.4%​11.5%​7.7%​(10) bps​370 bpsReturn on average tangible common equity (RoTCE)(f)​13.0%​13.1%​8.7%​(10) bps​430 bpsEfficiency Ratio (total operating expenses/total revenues, net)​57.4%​58.1%​62.7%​(70) bps​(530) bps14 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers21 May
  • 8-K​​​​​Citigroup($ in millions, except per share amounts and as otherwise noted)​ ​ ​1Q’26​ ​ ​4Q’25​ ​ ​1Q’25​ ​ ​QoQ%​ ​ ​YoY%Total revenues, net of interest expense​24,633​19,871​21,596​24%​14%​​​​​​​​​​​Total operating expenses​14,311​13,840​13,425​3%​7%​​​​​​​​​​​Net credit losses​2,208​2,190​2,459​1%​(10)%Net ACL build / (release)(a)​581​23​210​NM​177%Other provisions(b)​16​7​54​129%​(70)%Total provision for credit losses​2,805​2,220​2,723​26%​3%​​​​​​​​​​​Income (loss) from continuing operations before taxes​7,517​3,811​5,448​97%​38%Provision for income taxes​1,578​1,288​1,340​23%​18%Income (loss) from continuing operations​5,939​2,523​4,108​135%​45%Income (loss) from discontinued operations, net of taxes​(1)​(1)​(1)​-​-Net income attributable to non-controlling interest​153​51​43​200%​256%Citigroup’s net income (loss)​$5,785​$2,471​$4,064​134%​42%​​​​​​​​​​​​​​​​​​​​EOP loans ($B)​762​752​702​1%​8%Average loans ($B)​755​737​691​3%​9%EOP assets ($B)​2,778​2,657​2,572​5%​8%EOP deposits ($B)​1,446​1,404​1,316​3%​10%Average deposits ($B)​1,446​1,422​1,305​2%​11%​​​​​​​​​​​​​​​​​​​​Book value per share​$112.22​$110.01​$103.90​2%​8%Tangible book value per share(c)​$99.01​$97.06​$91.52​2%​8%Common Equity Tier 1 (CET1) Capital ratio(d)​12.7%​13.2%​13.4%​​​​Supplementary Leverage ratio (SLR)(d)​5.2%​5.5%​5.8%​​​​Return on average common equity (ROE)(e)​11.5%​4.5%​8.0%​​​​Return on average tangible common equity (RoTCE)(f)​13.1%​5.1%​9.1%​800 bps​400 bpsEfficiency Ratio (total operating expenses/total revenues, net)​58.1%​69.6%​62.2%​(1,150) bps​(410) bps14 Apr
  • 8-KCITIGROUP—QUARTERLY FINANCIAL DATA SUPPLEMENT4Q25 Historical​​​​​​ ​Page​Notes:In order to facilitate comparability with the Citigroup Inc. (Citi) first quarter of 2026 earnings materials to be issued on April 14, 2026, Citi is providing this Historical Quarterly Financial Data Supplement for the five-year quarterly and annual periods ended December 31, 2025, reflecting the following first quarter of 2026 reporting changes:*Citi transferred its Retail Banking business from U.S. Personal Banking (USPB) to Wealth and integrated the remaining USPB businesses into a new U.S. Consumer Cards segment. For additional information about these reporting changes, refer to Citi’s 2025 Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on February 20, 2026.-As part of this transfer, the financial results, balance sheet and tangible common equity (TCE) of the Retail Banking business moved to the Wealth segment.*Citi allocates TCE internally to its businesses annually, taking into consideration a variety of factors, including the economics of client relationships that cross businesses. In addition to reallocating TCE for the transfer of the businesses referenced above, in the first quarter 2026, Citi updated its TCE methodology among the Services, Markets and Banking segments to better align their capital usage associated with the shared economic benefits of corporate lending to clients across these segments, eliminating the need for a corporate lending revenue share arrangement, which had historically been reflected in the “All Other” revenue line item of these segments.-The updated methodology increased the allocated TCE of Services and Markets, decreased the allocated TCE of Banking, increased the revenues of Services and Markets and decreased the revenues of Banking.*Certain interest rate risk-management activities within Markets were moved to Corporate/Other, or between businesses within Markets. These changes impact the results for Markets, as well as Corporate/Other.Prior period results and TCE allocations for the segments referenced above have been recast to reflect these reporting changes. Citi’s consolidated results and TCE remain unchanged for all periods presented.Printing note:This Supplement is formatted to print on two pages for each sheet (due to the number of time periods included). The vertical header columns repeat on the second page of each sheet, but due to formatting constraints, the repeating footnotes on the second page are truncated. Please refer to the first page of each sheet for the full footnotes. Viewing in Excel or PDF is unaffected.​Citigroup​​​Financial Summary1​​Consolidated Statement of Income2​​Consolidated Balance Sheet3​​Segment Net Revenues and Income (Loss)4​​​​​​​Services5​​Markets6​​Banking7​​Wealth8​​U.S. Consumer Cards (USCC)9​​Metrics10​​All Other11​​Legacy Franchises12​​Corporate/Other13​​Divestiture-Related Impacts—Reconciling Items14​​​​​​​Citigroup Supplemental Detail​​​Average Balances and Interest Rates15​​EOP (End-of-Period) Loans16​​EOP Deposits17​​Allowance for Credit Losses (ACL) Rollforward18​​Allowance for Credit Losses on Loans (ACLL) and Unfunded Lending Commitments (ACLUC)19 - 20​​Non-Accrual Assets21​​Common Equity Tier 1 (CET1) Capital and Supplementary Leverage Ratios22​​Tangible Common Equity, Common Equity, Book Value per Share,Tangible Book Value Per Share (TBVPS) and Returns on Common Equity (RoCE) and Tangible Common Equity (RoTCE)23​​​​​​​Reconciliations of Adjusted Results and FX Impact​​​FX Impact24​​Total Citigroup Revenues, Net Interest Income (NII) and Non-Interest Revenues (NIR), and Total Citigroup Operating Expenses25​​Notable Items Adjustments and All Other (Managed Basis)26​​All Other (Managed Basis), and Legacy Franchises (Managed Basis)27​​Services and Banking—Corporate Lending Revenues28​​2021 - 2025 Annual—Total Citigroup Revenues, Total Operating Expenses, RoCE and RoTCE29​​Legacy Franchises Exits Contribution30​​​​​​3 Apr
  • 8-KOther Events12 Feb
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year12 Feb
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year3 Feb
  • 8-K​​​​​​​​​​​​​​Citigroup($ in millions, except per share amounts and as otherwise noted)​ ​ ​4Q’25​ ​ ​3Q’25​ ​ ​4Q’24​ ​ ​QoQ%​ ​ ​YoY%​​2025​ ​ ​2024​ ​ ​% Δ​​​​​​​​​​​​​​Total revenues, net of interest expense​​19,871​​22,090​​19,465​(10)%​2%​​​85,225​​80,722​6%​​​​​​​​​​​​​​Total operating expenses​​13,840​​14,290​​13,070​(3)%​6%​​​55,132​​53,567​3%​​​​​​​​​​​​​​Net credit losses​​2,190​​2,214​​2,242​(1)%​(2)%​​​9,097​​9,000​1%Net ACL build / (release)(a)​​23​​145​​203​(84)%​(89)%​​​602​​607​(1)%Other provisions(b)​​7​​91​​148​(92)%​(95)%​​​566​​502​13%Total provision for credit losses​​2,220​​2,450​​2,593​(9)%​(14)%​​​10,265​​10,109​2%​​​​​​​​​​​​​​Income (loss) from continuing operations before taxes​​3,811​​5,350​​3,802​(29)%​-​​​19,828​​17,046​16%Provision for income taxes​​1,288​​1,559​​912​(17)%​41%​​​5,373​​4,211​28%Income (loss) from continuing operations​​2,523​​3,791​​2,890​(33)%​(13)%​​​14,455​​12,835​13%Income (loss) from discontinued operations, net of taxes​​(1)​​(1)​​-​-​NM​​​(3)​​(2)​(50)%Net income attributable to non-controlling interest​​51​​38​​34​34%​50%​​​146​​151​(3)%Citigroup’s net income (loss)​$2,471​$3,752​$2,856​(34)%​(13)%​​$14,306​$12,682​13%​​​​​​​​​​​​​​​​​​​​​​​​​​​​EOP loans ($B)​​752​​734​​694​2%​8%​​​​​​Average loans ($B)​​737​​725​​688​2%​7%​​​​​​EOP assets ($B)​​2,657​​2,642​​2,353​1%​13%​​​​​​EOP deposits ($B)​​1,404​​1,384​​1,284​1%​9%​​​​​​Average deposits ($B)​​1,422​​1,382​​1,320​3%​8%​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Book value per share​$110.01​$108.41​$101.62​1%​8%​​$110.01​$101.62​8%Tangible book value per share(c)​$97.06​$95.72​$89.34​1%​9%​​$97.06​$89.34​9%Common Equity Tier 1 (CET1) Capital ratio(d)​​13.2%​​13.3%​​13.6%​​​​​13.2%​​13.6%​Supplementary Leverage ratio (SLR)(d)​​5.5%​​5.5%​​5.8%​​​​​5.5%​​5.8%​Return on average common equity (ROE)(e)​​4.5%​​7.1%​​5.4%​​​​​6.8%​​6.1%​Return on average tangible common equity (RoTCE)(f)​​5.1%​​8.0%​​6.1%​(290) bps​(100) bps​​​7.7%​​7.0%​70 bpsEfficiency Ratio (total operating expenses/total revenues, net)​​69.6%​​64.7%​​67.1%​490 bps​250 bps​​​64.7%​​66.4%​(170) bps​​​​​​​​​​​​​​​​​​​​​​​14 Jan
  • 8-KFinancial Statements and Exhibits12 Jan
  • 8-KOther Events29 Dec 2025
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year10 Dec 2025
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers20 Nov 2025

Insider Ownership(3.3K)

Expand
  • 3Initial statement of beneficial ownership23 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Oct
  • 4Statement of changes in beneficial ownership2 Jul
  • 4Statement of changes in beneficial ownership2 Jul
  • 4Statement of changes in beneficial ownership2 Jul
  • 4Statement of changes in beneficial ownership2 Jul

Beneficial Ownership(2.9K)

Expand
  • SC 13G/AWOLFSPEED, INC.5 Aug
  • SC 13G/APureTech Health plc11 May
  • SC 13GCITIGROUP INC29 Apr
  • SC 13G/ACITIGROUP INC26 Mar
  • SC 13GWOLFSPEED, INC.13 Feb
  • SC 13G/ASmartRent, Inc.10 Nov 2025
  • SC 13GPureTech Health plc11 Aug 2025
  • SC 13GNextCure, Inc.12 May 2025
  • SC 13G/ACITIGROUP INC24 Apr 2025
  • SC 13GSmartRent, Inc.12 Feb 2025
  • SC 13G/APureTech Health plc12 Feb 2025
  • SC 13G/AInnoviz Technologies Ltd.12 Feb 2025
  • SC 13GPureTech Health plc12 Nov 2024
  • SC 13GEAGLE PHARMACEUTICALS, INC.12 Nov 2024
  • SC 13G/AInnoviz Technologies Ltd.12 Nov 2024

Other Ownership(227)

Expand
  • 13F-HRQuarterly report (institutional investment manager holdings)3 Aug
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
  • 13F-HRQuarterly report (institutional investment manager holdings)11 May
  • 144DUGAN JOHN CUNNINGHAM8 May
  • 144Giles Nicole15 Apr
  • 144Skyler Edward15 Apr
  • 144Mason Mark20 Feb
  • 144Torres Cantu Ernesto13 Feb
  • 13F-HRQuarterly report (institutional investment manager holdings)13 Feb
  • 144LUCHETTI GONZALO12 Feb
  • 144Habner Pamela12 Feb
  • 144Giles Nicole11 Feb
  • 144Garg Sunil11 Feb
  • 13F-HRQuarterly report (institutional investment manager holdings)10 Nov 2025

Proxies(139)

Expand
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS30 Apr
  • ARSANNUAL REPORT TO SECURITY HOLDERS2 Apr
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS2 Apr
  • DEF 14ADEFINITIVE PROXY STATEMENT2 Apr
  • PX14A6GNotice of exempt solicitation28 Apr 2025
  • PX14A6GNotice of exempt solicitation14 Apr 2025
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS2 Apr 2025
  • ARSAnnual report to security holders19 Mar 2025
  • DEFA14ADefinitive additional materials18 Mar 2025
  • DEF 14ADEFINITIVE PROXY STATEMENT18 Mar 2025
  • PX14A6GNotice of exempt solicitation11 Apr 2024
  • PX14A6GNotice of exempt solicitation10 Apr 2024
  • PX14A6GNotice of exempt solicitation4 Apr 2024
  • PX14A6GNotice of exempt solicitation26 Mar 2024
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS22 Mar 2024

Registrations(85.4K)

Expand
  • 424B3AMENDED AND RESTATED PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • FWPOFFERING SUMMARY23 Oct
  • FWPOFFERING SUMMARY23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRICING SUPPLEMENT23 Oct
  • 424B2Prospectus filing (Rule 424(b)(2))23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRICING SUPPLEMENT23 Oct
  • FWPFree writing prospectus23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct
  • 424B2PRELIMINARY PRICING SUPPLEMENT23 Oct

Filing Review Correspondence(44)

Expand
  • CORRESPFiling review correspondence10 Jul 2024
  • CORRESPFiling review correspondence6 Jun 2022
  • CORRESPFiling review correspondence10 May 2022
  • CORRESPFiling review correspondence7 May 2021
  • CORRESPFiling review correspondence11 Feb 2021
  • CORRESPFiling review correspondence1 Oct 2020
  • CORRESPFiling review correspondence22 Aug 2019
  • CORRESPFiling review correspondence10 May 2018
  • CORRESPFiling review correspondence5 Apr 2017
  • CORRESPFiling review correspondence29 Mar 2017
  • CORRESPFiling review correspondence3 Aug 2016
  • CORRESPFiling review correspondence12 Jul 2016
  • UPLOADFiling review upload1 Aug 2013
  • CORRESPFiling review correspondence22 Jul 2013
  • UPLOADFiling review upload8 Jul 2013

SEC Orders And Notices(12)

Expand
  • EFFECTNotice of effectiveness11 May 2021
  • EFFECTNotice of effectiveness14 May 2018
  • EFFECTNotice of effectiveness7 Apr 2017
  • CT ORDERConfidential treatment order9 Jan 2015
  • EFFECTNotice of effectiveness9 Sep 2013
  • EFFECTNotice of effectiveness4 Feb 2013
  • EFFECTNotice of effectiveness12 May 2011
  • EFFECTNotice of effectiveness12 May 2011
  • EFFECTNotice of effectiveness12 May 2011
  • EFFECTNotice of effectiveness20 Apr 2011
  • EFFECTNotice of effectiveness17 Jul 2009
  • EFFECTNotice of effectiveness16 Nov 2007

Tender Offers And Going Private(17)

Expand
  • SC 14D9INVESCO VAN KAMPEN SENIOR INCOME TRUST SC13G-A 12-31-201011 Apr 2011
  • SC TO-I/AAMENDMENT NO. 2 TO SCHEDULE TO31 Jul 2009
  • SC TO-I/AAMENDMENT NO. 1 TO SCHEDULE TO17 Jul 2009
  • SC TO-ISCHEDULE TO18 Jun 2009
  • SC TO-TTender offer statement (third-party)26 Apr 2000
  • SC TO-TTender offer statement (third-party)20 Apr 2000
  • SC TO-TTender offer statement (third-party)19 Apr 2000
  • SC 14D9/ASolicitation/recommendation statement (amendment)17 Apr 2000
  • SC TO-TTender offer statement (third-party)14 Apr 2000
  • SC TO-TTender offer statement (third-party)6 Apr 2000
  • SC 14D9/ASolicitation/recommendation statement (amendment)6 Apr 2000
  • SC TO-TTender offer statement (third-party)5 Apr 2000
  • SC 14D9/ASolicitation/recommendation statement (amendment)5 Apr 2000
  • SC TO-T/ATender offer statement (third-party, amendment)30 Mar 2000
  • SC TO-T/ATender offer statement (third-party, amendment)24 Mar 2000

Other(214)

Expand
  • IRANNOTICEIRANNOTICE20 Feb
  • CERTCERT4 Feb
  • IRANNOTICEIRANNOTICE6 Nov 2025
  • 25NOTES DELISTING NOTIFICATION12 May 2025
  • IRANNOTICEIRANNOTICE8 May 2025
  • IRANNOTICEIRANNOTICE24 Feb 2025
  • IRANNOTICEIRANNOTICE2 Aug 2024
  • IRANNOTICEIRANNOTICE3 May 2024
  • IRANNOTICEIRANNOTICE23 Feb 2024
  • IRANNOTICEIRANNOTICE3 Nov 2023
  • IRANNOTICEIRANNOTICE4 Aug 2023
  • IRANNOTICEIRANNOTICE5 May 2023
  • IRANNOTICEIRANNOTICE27 Feb 2023
  • IRANNOTICEIRANNOTICE10 May 2022
  • CERTCERT6 Apr 2022